Mechanical forces impact cardiac cells and tissues over their entire lifespan, from development to growth and eventually to pathophysiology. However, the mechanobiological pathways that drive cell and tissue responses to mechanical forces are only now beginning to be understood, due in part to the challenges in replicating the evolving dynamic microenvironments of cardiac cells and tissues in a laboratory setting. Although many in vitro cardiac models have been established to provide specific stiffness, topography, or viscoelasticity to cardiac cells and tissues via biomaterial scaffolds or external stimuli, technologies for presenting time-evolving mechanical microenvironments have only recently been developed. In this review, we summarize the range of in vitro platforms that have been used for cardiac mechanobiological studies. We provide a comprehensive review on phenotypic and molecular changes of cardiomyocytes in response to these environments, with a focus on how dynamic mechanical cues are transduced and deciphered. We conclude with our vision of how these findings will help to define the baseline of heart pathology and of how these in vitro systems will potentially serve to improve the development of therapies for heart diseases.
References
1.
J. G.
Jacot
, J. C.
Martin
, and D. L.
Hunt
, “Mechanobiology of cardiomyocyte development
,” J. Biomech.
43
, 93
–98
(2010
).2.
S. P.
Sheehy
, A.
Grosberg
, and K. K.
Parker
, “The contribution of cellular mechanotransduction to cardiomyocyte form and function
,” Biomech. Model. Mechanobiol.
11
, 1227
–1239
(2012
).3.
S.
Majkut
et al., “Heart-specific stiffening in early embryos parallels matrix and myosin expression to optimize beating
,” Curr. Biol.
23
, 2434
–2439
(2013
).4.
J.
Münch
and S.
Abdelilah-Seyfried
, “Sensing and responding of cardiomyocytes to changes of tissue stiffness in the diseased heart
,” Front. Cell Dev. Biol.
9
, 642840
(2021
).5.
C. L.
Happe
and A. J.
Engler
, “Mechanical forces reshape differentiation cues that guide cardiomyogenesis
,” Circ. Res.
118
, 296
–310
(2016
).6.
S. W.
Patterson
, H.
Piper
, and E. H.
Starling
, “The regulation of the heart beat
,” J. Physiol.
48
, 465
–513
(1914
).7.
G.
von Anrep
, “On the part played by the suprarenals in the normal vascular reactions of the body
,” J. Physiol.
45
, 307
–317
(1912
).8.
A. P.
Voorhees
and H.-C.
Han
, “Biomechanics of cardiac function
,” Compr. Physiol.
5
, 1623
–1644
(2015
).9.
V.
Schwach
and R.
Passier
, “Native cardiac environment and its impact on engineering cardiac tissue
,” Biomater. Sci.
7
, 3566
–3580
(2019
).10.
C.
Hall
, K.
Gehmlich
, C.
Denning
, and D.
Pavlovic
, “Complex relationship between cardiac fibroblasts and cardiomyocytes in health and disease
,” J. Am. Heart Assoc.
10
, e019338
(2021
).11.
Z.
Li
et al., “Thermosensitive and highly flexible hydrogels capable of stimulating cardiac differentiation of cardiosphere-derived cells under static and dynamic mechanical training conditions
,” ACS Appl. Mater. Interfaces
8
, 15948
–15957
(2016
).12.
I.
Shimizu
and T.
Minamino
, “Physiological and pathological cardiac hypertrophy
,” J. Mol. Cell. Cardiol.
97
, 245
–262
(2016
).13.
R. C.
Lyon
, F.
Zanella
, J. H.
Omens
, and F.
Sheikh
, “Mechanotransduction in cardiac hypertrophy and failure
,” Circ. Res.
116
, 1462
–1476
(2015
).14.
Z. K.
Haque
and D.-Z.
Wang
, “How cardiomyocytes sense pathophysiological stresses for cardiac remodeling
,” Cell. Mol. Life Sci.
74
, 983
–1000
(2017
).15.
K.
Kuwahara
, T.
Nishikimi
, and K.
Nakao
, “Transcriptional regulation of the fetal cardiac gene program
,” J. Pharmacol. Sci.
119
, 198
–203
(2012
).16.
I.
Shiojima
et al., “Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure
,” J. Clin. Invest.
115
, 2108
–2118
(2005
).17.
M.
Nakamura
and J.
Sadoshima
, “Mechanisms of physiological and pathological cardiac hypertrophy
,” Nat. Rev. Cardiol.
15
, 387
–407
(2018
).18.
O. J.
Abilez
et al., “Passive stretch induces structural and functional maturation of engineered heart muscle as predicted by computational modeling
,” Stem Cells
36
, 265
–277
(2018
).19.
P. A.
Galie
, N.
Khalid
, K. E.
Carnahan
, M. V.
Westfall
, and J. P.
Stegemann
, “Substrate stiffness affects sarcomere and costamere structure and electrophysiological function of isolated adult cardiomyocytes
,” Cardiovasc. Pathol.
22
, 219
–227
(2013
).20.
M. R.
Salick
et al., “Micropattern width dependent sarcomere development in human ESC-derived cardiomyocytes
,” Biomaterials
35
, 4454
–4464
(2014
).21.
J.
Guo
et al., “Interplay of genotype and substrate stiffness in driving the hypertrophic cardiomyopathy phenotype in iPSC-micro-heart muscle arrays
,” Cell. Mol. Bioeng.
14
, 409
–425
(2021
).22.
I.
Jorba
et al., “In vitro methods to model cardiac mechanobiology in health and disease
,” Tissue Eng. Part C
27
, 139
–151
(2021
).23.
J.
Zhuang
, K. A.
Yamada
, J. E.
Saffitz
, and A. G.
Kleber
, “Pulsatile stretch remodels cell-to-cell communication in cultured myocytes
,” Circ. Res.
87
, 316
(2000
).24.
B.
Russell
, M. W.
Curtis
, Y. E.
Koshman
, and A. M.
Samarel
, “Mechanical stress-induced sarcomere assembly for cardiac muscle growth in length and width
,” J. Mol. Cell. Cardiol.
48
, 817
–823
(2010
).25.
B.
Özkale
, M. S.
Sakar
, and D. J.
Mooney
, “Active biomaterials for mechanobiology
,” Biomaterials
267
, 120497
(2021
).26.
H.
Shi
, C.
Wang
, and Z.
Ma
, “Stimuli-responsive biomaterials for cardiac tissue engineering and dynamic mechanobiology
,” APL Bioeng.
5
, 011506
(2021
).27.
A. O.
Melleby
et al., “A novel method for high precision aortic constriction that allows for generation of specific cardiac phenotypes in mice
,” Cardiovasc. Res.
114
, 1680
–1690
(2018
).28.
M.
Turcani
and H.
Rupp
, “Heart failure development in rats with ascending aortic constriction and angiotensin-converting enzyme inhibition
,” Br. J. Pharmacol.
130
, 1671
–1677
(2000
).29.
M. E.
Young
, F. A.
Laws
, G. W.
Goodwin
, and H.
Taegtmeyer
, “Reactivation of peroxisome proliferator-activated receptor α is associated with contractile dysfunction in hypertrophied rat heart
,” J. Biol. Chem.
276
, 44390
–44395
(2001
).30.
B.
Swynghedauw
, “Molecular mechanisms of myocardial remodeling
,” Physiol. Rev.
79
, 215
–262
(1999
).31.
K. T.
Weber
and C. G.
Brilla
, “Pathological hypertrophy and cardiac interstitium: Fibrosis renin-angiotensin-aldosterone system
,” Circulation
83
, 1849
–1865
(1991
).32.
E.
Balcells
, Q. C.
Meng
, W. H.
Johnson
, S.
Oparil
, and L. J.
Dell'Italia
, “Angiotensin II formation from ACE and chymase in human and animal hearts: Methods and species considerations
,” Am. J. Physiol.-Heart Circ. Physiol.
273
, H1769
–H1774
(1997
).33.
H.
Sekine
, T.
Shimizu
, S.
Kosaka
, E.
Kobayashi
, and T.
Okano
, “Cardiomyocyte bridging between hearts and bioengineered myocardial tissues with mesenchymal transition of mesothelial cells
,” J. Heart Lung Transplant.
25
, 324
–332
(2006
).34.
T.
Kofidis
, L.
Balsam
, J.
de Bruin
, and R. C.
Robbins
, “Distinct cell-to-fiber junctions are critical for the establishment of cardiotypical phenotype in a 3D bioartificial environment
,” Med. Eng. Phys.
26
, 157
–163
(2004
).35.
H.
Watkins
, H.
Ashrafian
, and C. S.
Redwood
, “Inherited cardiomyopathies
,” New England J. Med.
364
, 1643
–1656
(2011
).36.
E.
Gandjbakhch
et al., “Screening of genes encoding junctional candidates in arrhythmogenic right ventricular cardiomyopathy/dysplasia
,” Europace
15
, 1522
–1525
(2013
).37.
B.
Klauke
et al., “De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy
,” Hum. Mol. Genet.
19
, 4595
–4607
(2010
).38.
C.
Basso
, D.
Corrado
, F. I.
Marcus
, A.
Nava
, and G.
Thiene
, “Arrhythmogenic right ventricular cardiomyopathy
,” Lancet
373
, 1289
–1300
(2009
).39.
Z.
Zhang
et al., “Normalization of Naxos plakoglobin levels restores cardiac function in mice
,” J. Clin. Invest.
125
, 1708
–1712
(2015
).40.
N. A.
Chitaev
et al., “The binding of plakoglobin to desmosomal cadherins: Patterns of binding sites and topogenic potential
,” J. Cell Biol.
133
, 359
–369
(1996
).41.
E. K.
Biernacka
et al., “Pathogenic variants in plakophilin-2 gene (PKP2) are associated with better survival in arrhythmogenic right ventricular cardiomyopathy
,” J. Appl. Genet.
62
, 613
–620
(2021
).42.
T. B.
Rasmussen
et al., “Truncating plakophilin-2 mutations in arrhythmogenic cardiomyopathy are associated with protein haploinsufficiency in both myocardium and epidermis
,” Circ. Cardiovasc. Genet.
7
, 230
–240
(2014
).43.
B.
Gerull
and A.
Brodehl
, “Genetic animal models for arrhythmogenic cardiomyopathy
,” Front. Physiol.
11
, 624
–624
(2020
).44.
R. D.
Patten
and M. R.
Hall-Porter
, “Small animal models of heart failure
,” Circ.: Heart Failure
2
, 138
–144
(2009
).45.
D.
Barefield
, M.
Kumar
, P. P.
de Tombe
, and S.
Sadayappan
, “Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy
,” Am. J. Physiol. Heart Circ. Physiol.
306
, H807
–H815
(2014
).46.
P. Y.
Sato
et al., “Interactions between ankyrin-G, plakophilin-2, and connexin43 at the cardiac intercalated disc
,” Circ. Res.
109
, 193
–201
(2011
).47.
M.
Noorman
et al., “Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy
,” Heart Rhythm
10
, 412
–419
(2013
).48.
M.
Cerrone
et al., “Plakophilin-2 is required for transcription of genes that control calcium cycling and cardiac rhythm
,” Nat. Commun.
8
, 106
(2017
).49.
W. C.
Claycomb
, J. B.
Delcarpio
, S. E.
Guice
, and R. L.
Moses
, “Culture and characterization of fetal human atrial and ventricular cardiac muscle cells
,” In Vitro Cell. Dev. Biol.
25
, 1114
–1120
(1989
).50.
E.
Ergir
et al., “Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture
,” Sci. Rep.
12
, 17409
(2022
).51.
T.
Shimizu
et al., “Fabrication of pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces
,” Circ. Res.
90
, e40
(2002
).52.
T.
Shimizu
et al., “Long-term survival and growth of pulsatile myocardial tissue grafts engineered by the layering of cardiomyocyte sheets
,” Tissue Eng.
12
, 499
(2006
).53.
H.
Yang
et al., “Transcriptome analysis of non human primate-induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer culture vs 3D engineered heart tissue
,” Cardiovasc. Res.
117
, 2125
–2136
(2021
).54.
M.
Chiquet
, L.
Gelman
, R.
Lutz
, and S.
Maier
, “From mechanotransduction to extracellular matrix gene expression in fibroblasts
,” Biochim. Biophys. Acta, Mol. Cell Res.
1793
, 911
–920
(2009
).55.
M. S.
Kolodney
and E. L.
Elson
, “Correlation of myosin light chain phosphorylation with isometric contraction of fibroblasts
,” J. Biol. Chem.
268
, 23850
–23855
(1993
).56.
M. S.
Kolodney
and R. B.
Wysolmerski
, “Isometric contraction by fibroblasts and endothelial cells in tissue culture: A quantitative study
,” J. Cell Biol.
117
, 73
–82
(1992
).57.
E. L.
Elson
and G. M.
Genin
, “Tissue constructs: Platforms for basic research and drug discovery
,” Interface Focus
6
, 20150095
(2016
).58.
T.
Eschenhagen
et al., “Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: A new heart muscle model system
,” FASEB J.
11
, 683
–694
(1997
).59.
H.
Vandenburgh
et al., “Drug-screening platform based on the contractility of tissue-engineered muscle
,” Muscle Nerve
37
, 438
–447
(2008
).60.
J. P.
Marquez
et al., “High-throughput measurements of hydrogel tissue construct mechanics
,” Tissue Eng. Part C
15
, 181
–190
(2009
).61.
T.
Boudou
et al., “A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues
,” Tissue Eng. Part A
18
, 910
–919
(2012
).62.
N. L.
Tulloch
et al., “Growth of engineered human myocardium with mechanical loading and vascular coculture
,” Circ. Res.
109
, 47
–59
(2011
).63.
J. M.
Bliley
et al., “Dynamic loading of human engineered heart tissue enhances contractile function and drives a desmosome-linked disease phenotype
,” Sci. Transl. Med.
13
, eabd1817
(2021
).64.
X.
Sun
and S. S.
Nunes
, “Biowire platform for maturation of human pluripotent stem cell-derived cardiomyocytes
,” Methods
101
, 21
–26
(2016
).65.
D. W.
Simmons
et al., “Hydrogel assisted double molding of 3D-print enables prestress regulation of micro-heart muscle physiology
,” bioRxiv:2022.07.23.501265 (2022
).66.
J.
Guo
et al., “Elastomer-grafted iPSC-derived micro heart muscles to investigate effects of mechanical loading on physiology
,” ACS Biomater. Sci. Eng.
7
, 2973
–2989
(2020
).67.
C. A.
Blair
and B. L.
Pruitt
, “Mechanobiology assays with applications in cardiomyocyte biology and cardiotoxicity
,” Adv. Healthcare Mater.
9
, 1901656
(2020
).68.
K.
Toischer
et al., “Differential cardiac remodeling in preload versus afterload
,” Circulation
122
, 993
–1003
(2010
).69.
M. L.
McCain
, H.
Lee
, Y.
Aratyn-Schaus
, A. G.
Kléber
, and K. K.
Parker
, “Cooperative coupling of cell-matrix and cell-cell adhesions in cardiac muscle
,” Proc. Natl. Acad. Sci. U. S. A.
109
, 9881
–9886
(2012
).70.
H.
Shi
, C.
Wang
, B. Z.
Gao
, J. H.
Henderson
, and Z.
Ma
, “Cooperation between myofibril growth and costamere maturation in human cardiomyocytes
,” Front. Bioeng. Biotechnol.
10
, 1049523
(2022
).71.
S.
Sun
et al., “Progressive myofibril reorganization of human cardiomyocytes on a dynamic nanotopographic substrate
,” ACS Appl. Mater. Interfaces
12
, 21450
–21462
(2020
).72.
H.
Shi
et al., “Profiling the responsiveness of focal adhesions of human cardiomyocytes to extracellular dynamic nano-topography
,” Bioact. Mater.
10
, 367
–377
(2021
).73.
P. Y.
Mengsteab
et al., “Spatiotemporal control of cardiac anisotropy using dynamic nanotopographic cues
,” Biomaterials
86
, 1
–10
(2016
).74.
K. M.
Broughton
and B.
Russell
, “Cardiomyocyte subdomain contractility arising from microenvironmental stiffness and topography
,” Biomech. Model. Mechanobiol.
14
, 589
–602
(2015
).75.
A. J. S.
Ribeiro
et al., “Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness
,” Proc. Natl. Acad. Sci. U. S. A.
112
, 12705
–12710
(2015
).76.
M.
Ibrahim
et al., “Cardiomyocyte Ca2+ handling and structure is regulated by degree and duration of mechanical load variation
,” J. Cell. Mol. Med.
16
, 2910
–2918
(2012
).77.
S. D.
Boothe
et al., “The effect of substrate stiffness on cardiomyocyte action potentials
,” Cell. Biochem. Biophys.
74
, 527
–535
(2016
).78.
G.
Iribe
, M.
Helmes
, and P.
Kohl
, “Force-length relations in isolated intact cardiomyocytes subjected to dynamic changes in mechanical load
,” Am. J. Physiol.-Heart Circ. Physiol.
292
, H1487
–H1497
(2007
).79.
J.
Sadoishima
, Y.
Xu
, H. S.
Slayter
, and S.
Izumo
, “Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro
,” Cell
75
, 977
–984
(1993
).80.
T.
Yamazaki
et al., “Role of ion channels and exchangers in mechanical stretch-induced cardiomyocyte hypertrophy
,” Circ. Res.
82
, 430
–437
(1998
).81.
O. F.
Bueno
et al., “The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
,” EMBO J.
19
, 6341
–6350
(2000
).82.
Y.
Seko
et al., “Pulsatile stretch activates mitogen-activated protein kinase (MAPK) family members and focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes
,” Biochem. Biophys. Res. Commun.
259
, 8
–14
(1999
).83.
K. G.
Shyu
, C. C.
Chen
, B. W.
Wang
, and P.
Kuan
, “Angiotensin II receptor antagonist blocks the expression of connexin43 induced by cyclical mechanical stretch in cultured neonatal rat cardiac myocytes
,” J. Mol. Cell. Cardiol.
33
, 691
–698
(2001
).84.
S. M.
Gopalan
et al., “Anisotropic stretch-induced hypertrophy in neonatal ventricular myocytes micropatterned on deformable elastomers
,” Biotechnol. Bioeng.
81
, 578
–587
(2003
).85.
S.
Dhein
et al., “Mechanical control of cell biology: Effects cyclic mechanical stretch cardiomyocyte cellular organization
,” Prog. Biophys. Mol. Biol.
115
, 93
–102
(2014
).86.
X.
Yang
, L.
Pabon
, and C. E.
Murry
, “Engineering adolescence: Maturation of human pluripotent stem cell-derived cardiomyocytes
,” Circ. Res.
114
, 511
–523
(2014
).87.
C. W.
van den Berg
et al., “Transcriptome of human foetal heart compared with cardiomyocytes from pluripotent stem cells
,” Development
142
, 3231
–3238
(2015
).88.
J. C.
Garbern
et al., “Inhibition of mTOR signaling enhances maturation of cardiomyocytes derived from human-induced pluripotent stem cells via p53-induced quiescence
,” Circulation
141
, 285
–300
(2020
).89.
R. J.
Mills
et al., “Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest
,” Proc. Natl. Acad. Sci. U. S. A.
114
, E8372
–E8381
(2017
).90.
N.
Huebsch
et al., “Metabolically driven maturation of human-induced-pluripotent-stem-cell-derived cardiac microtissues on microfluidic chips
,” Nat. Biomed. Eng.
6
, 372
–388
(2022
).91.
N. Y.
Liaw
and W.-H.
Zimmermann
, “Mechanical stimulation in the engineering of heart muscle
,” Adv. Drug Delivery Rev.
96
, 156
–160
(2016
).92.
Y.
Yahalom-Ronen
, D.
Rajchman
, R.
Sarig
, B.
Geiger
, and E.
Tzahor
, “Reduced matrix rigidity promotes neonatal cardiomyocyte dedifferentiation, proliferation and clonal expansion
,” Elife
4
, e07455
(2015
).93.
P. P. S. S.
Abadi
et al., “Engineering of mature human induced pluripotent stem cell‐derived cardiomyocytes using substrates with multiscale topography
,” Adv. Funct. Mater.
28
, 1707378
(2018
).94.
J. L.
Young
and A. J.
Engler
, “Hydrogels with time-dependent material properties enhance cardiomyocyte differentiation in vitro
,” Biomaterials
32
, 1002
–1009
(2011
).95.
J.
Kreutzer
et al., “Pneumatic unidirectional cell stretching device for mechanobiological studies of cardiomyocytes
,” Biomech. Model. Mechanobiol.
19
, 291
–303
(2020
).96.
A.
Agrawal
et al., “Stimuli-responsive liquid crystal elastomers for dynamic cell culture
,” J. Mater. Res.
30
, 453
–462
(2015
).97.
Y.
Zhang
et al., “Mechanical model of the physiological microenvironment of cardiomyocytes
,” Appl. Nanosci.
13
, 1201
(2021
).98.
T. J.
Kolanowski
et al., “Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system
,” Acta Biomater.
102
, 273
–286
(2020
).99.
K.
Ronaldson-Bouchard
et al., “Advanced maturation of human cardiac tissue grown from pluripotent stem cells
,” Nature
556
, 239
–243
(2018
).100.
W.
Dou
et al., “A microdevice platform for characterizing the effect of mechanical strain magnitudes on the maturation of iPSC-cardiomyocytes
,” Biosens. Bioelectron.
175
, 112875
(2021
).101.
N.
Shen
et al., “Steps toward maturation of embryonic stem cell-derived cardiomyocytes by defined physical signals
,” Stem Cell Rep.
9
, 122
–135
(2017
).102.
M.
Song
et al., “Development of magnetic torque stimulation (MTS) utilizing rotating uniform magnetic field for mechanical activation of cardiac cells
,” Nanomaterials
10
, 1684
(2020
).103.
W. W.
Sharp
, D. G.
Simpson
, T. K.
Borg
, A. M.
Samarel
, and L.
Terracio
, “Mechanical forces regulate focal adhesion and costamere assembly in cardiac myocytes,” Am.
J. Physiol. Heart Circ. Physiol.
273
, H546
(1997
).104.
A. A.
Abdeen
, J.
Lee
, N. A.
Bharadwaj
, R. H.
Ewoldt
, and K. A.
Kilian
, “Temporal modulation of stem cell activity using magnetoactive hydrogels
,” Adv. Healthcare Mater.
5
, 2536
–2544
(2016
).105.
E. A.
Corbin
et al., “Tunable and reversible substrate stiffness reveals a dynamic mechanosensitivity of cardiomyocytes
,” ACS Appl. Mater. Interfaces
11
, 20603
–20614
(2019
).106.
Y. C.
Yeh
et al., “Mechanically dynamic PDMS substrates to investigate changing cell environments
,” Biomaterials
145
, 23
–32
(2017
).107.
C.
Yang
, M. W.
Tibbitt
, L.
Basta
, and K. S.
Anseth
, “Mechanical memory and dosing influence stem cell fate
,” Nat. Mater.
13
, 645
–652
(2014
).108.
J. D.
Kijlstra
et al., “Integrated analysis of contractile kinetics, force generation, and electrical activity in single human stem cell-derived cardiomyocytes
,” Stem Cell Rep.
5
, 1226
–1238
(2015
).109.
L.
Sala
et al., “MUSCLEMOTION: A versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo
,” Circ. Res.
122
, e5
–e16
(2018
).110.
I.
Mannhardt
et al., “Human engineered heart tissue: Analysis of contractile force
,” Stem Cell Rep.
7
, 29
–42
(2016
).111.
M.
Takeda
et al., “Development of in vitro drug-induced cardiotoxicity assay by using three-dimensional cardiac tissues derived from human induced pluripotent stem cells
,” Tissue Eng., Part C
24
, 56
–67
(2018
).112.
I.
Mannhardt
, C.
Warncke
, H. K.
Trieu
, J.
Muller
, and T.
Eschenhagen
, “Piezo-bending actuators for isometric or auxotonic contraction analysis of engineered heart tissue
,” J. Tissue Eng. Regener. Med.
13
, 3
–11
(2019
).113.
G.
Conant
et al., “High-content assessment of cardiac function using heart-on-a-chip devices as drug screening model
,” Stem Cell Rev. Rep.
13
, 335
–346
(2017
).114.
A.
Hansen
et al., “Development of a drug screening platform based on engineered heart tissue
,” Circ. Res.
107
, 35
–44
(2010
).115.
A. J. S.
Ribeiro
et al., “Multi-imaging method to assay the contractile mechanical output of micropatterned human iPSC-derived cardiac myocytes
,” Circ. Res.
120
, 1572
–1583
(2017
).116.
Z.
Ma
et al., “Three-dimensional filamentous human diseased cardiac tissue model
,” Biomaterials
35
, 1367
–1377
(2014
).117.
R.
Truitt
et al., “Increased afterload augments sunitinib-induced cardiotoxicity in an engineered cardiac microtissue model
,” JACC Basic Transl. Sci.
3
, 265
–276
(2018
).118.
Z.
Jian
et al., “Mechanochemotransduction during cardiomyocyte contraction is mediated by localized nitric oxide signaling
,” Sci. Signal
7
, ra27
(2014
).119.
A.
Leonard
et al., “Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues
,” J. Mol. Cell. Cardiol.
118
, 147
–158
(2018
).120.
M. L.
Rodriguez
, T. R.
Werner
, B.
Becker
, T.
Eschenhagen
, and M. N.
Hirt
, “A magnetics-based approach for fine-tuning afterload in engineered heart tissues
,” ACS Biomater. Sci. Eng.
5
, 3663
–3675
(2019
).121.
M. N.
Hirt
et al., “Increased afterload induces pathological cardiac hypertrophy: A new in vitro model
,” Basic Res. Cardiol.
107
, 307
(2012
).122.
H.
Parsa
, B. Z.
Wang
, and G.
Vunjak-Novakovic
, “A microfluidic platform for the high-throughput study of pathological cardiac hypertrophy
,” Lab Chip
17
, 3264
–3271
(2017
).123.
Z.
Ma
et al., “Contractile deficits in engineered cardiac microtissues as a result of MYBPC3 deficiency and mechanical overload
,” Nat. Biomed. Eng.
2
, 955
–967
(2018
).124.
T. Y.
Wong
et al., “Mechanical Stretching simulates cardiac physiology and pathology through mechanosensor Piezo1
,” J. Clin. Med.
7
, 410
(2018
).125.
S.
Martewicz
et al., “Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli
,” Ann. Biomed. Eng.
47
, 852
–865
(2019
).126.
H.
Yang
et al., “Dynamic myofibrillar remodeling in live cardiomyocytes under static stretch
,” Sci. Rep.
6
, 20674
(2016
).127.
F.
Sheikh
, R. S.
Ross
, and J.
Chen
, “Cell–cell connection to heart disease
,” Trends Cardiovasc. Med.
19
, 182
–190
(2009
).128.
D. E.
Ingber
, “Mechanobiology and diseases of mechanotransduction
,” Ann. Med.
35
, 564
–577
(2003
).129.
A.
Asimaki
et al., “Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy
,” Sci. Transl. Med.
6
, 240ra74
(2014
).130.
A. La
Gerche
, D. J.
Rakhit
, and G.
Claessen
, “Exercise and the right ventricle: A potential Achilles' heel
,” Cardiovasc. Res.
113
, 1499
–1508
(2017
).131.
L.
Fabritz
et al., “Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice
,” J. Am. Coll. Cardiol.
57
, 740
–750
(2011
).132.
S.
Israeli-Rosenberg
, A. M.
Manso
, H.
Okada
, and R. S.
Ross
, “Integrins and integrin-associated proteins in the cardiac myocyte
,” Circ. Res.
114
, 572
–586
(2014
).133.
A.
Angulo-Urarte
, T.
van der Wal
, and S.
Huveneers
, “Cell–cell junctions as sensors and transducers of mechanical forces
,” Biochim. Biophys. Acta, Biomembr.
1862
, 183316
(2020
).134.
A.
Hartsock
and W. J.
Nelson
, “Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton
,” Biochim. Biophys. Acta
1778
, 660
–669
(2008
).135.
Q.
le Duc
et al., “Vinculin potentiates E-cadherin mechanosensing and is recruited to actin-anchored sites within adherens junctions in a myosin II-dependent manner
,” J. Cell Biol.
189
, 1107
–1115
(2010
).136.
J.
Li
et al., “Alpha-catenins control cardiomyocyte proliferation by regulating yap activity
,” Circ. Res.
116
, 70
–79
(2015
).137.
K. J.
Green
, A.
Jaiganesh
, and J. A.
Broussard
, “Desmosomes: Essential contributors to an integrated intercellular junction network
,” F1000Research
8
, F1000
(2019
).138.
C.
Basso
, B.
Bauce
, D.
Corrado
, and G.
Thiene
, “Pathophysiology of arrhythmogenic cardiomyopathy
,” Nat. Rev. Cardiol.
9
, 223
–233
(2011
).139.
R.
Lombardi
et al., “Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy
,” Circ. Res.
104
, 1076
–1084
(2009
).140.
M.
Krüger
and W. A.
Linke
, “Titin-based mechanical signalling in normal and failing myocardium
,” J. Mol. Cell. Cardiol.
46
, 490
–498
(2009
).141.
M.
Hongo
et al., “Effects of growth hormone on cardiac dysfunction and gene expression in genetic murine dilated cardiomyopathy
,” Basic Res. Cardiol.
95
, 431
–441
(2000
).142.
J. T.
Hinson
et al., “Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy
,” Science
349
, 982
–986
(2015
).143.
M.
Reconditi
et al., “Myosin filament activation in the heart is tuned to the mechanical task
,” Proc. Natl. Acad. Sci. U. S. A.
114
, 3240
–3245
(2017
).144.
A.
Chopra
et al., “Force generation via β-cardiac myosin, titin, and α-actinin drives cardiac sarcomere assembly from cell-matrix adhesions
,” Dev. Cell.
44
, 87
–96
(2018
).145.
S. R.
Clippinger
et al., “Disrupted mechanobiology links the molecular and cellular phenotypes in familial dilated cardiomyopathy
,” Proc. Natl. Acad. Sci. U. S. A.
116
, 17831
–17840
(2019
).146.
J. P.
Kerr
et al., “Detyrosinated microtubules modulate mechanotransduction in heart and skeletal muscle
,” Nat. Commun.
6
, 8526
–8526
(2015
).147.
M. A.
Caporizzo
, C. Y.
Chen
, K.
Bedi
, K. B.
Margulies
, and B. L.
Prosser
, “Microtubules increase diastolic stiffness in failing human cardiomyocytes and myocardium
,” Circulation
141
, 902
–915
(2020
).148.
J. A.
Meier
et al., “Stress-induced dynamic regulation of mitochondrial STAT3 and its association with cyclophilin D reduce mitochondrial ROS production
,” Sci. Signaling
10
, eaag2588
(2017
).149.
S.
Yashirogi
et al., “AMPK regulates cell shape of cardiomyocytes by modulating turnover of microtubules through CLIP-170
,” EMBO Rep.
22
, e50949
(2021
).150.
D.
Kelly
, L.
Mackenzie
, P.
Hunter
, B.
Smaill
, and D. A.
Saint
, “Gene expression of stretch-activated channels and mechanoelectric feedback in the heart
,” Clin. Exp. Pharmacol. Physiol.
33
, 642
–648
(2006
).151.
Z.
Pedrozo
et al., “Polycystin-1 is a cardiomyocyte mechanosensor that governs L-type Ca2+ channel protein stability
,” Circulation
131
, 2131
–2142
(2015
).152.
G. L.
Bakris
and M.
Sorrentino
, Hypertension: A Companion to Braunwald's Heart Disease
(Elsevier Health Sciences
, 2017
).153.
G.
Iribe
et al., “Axial stretch of rat single ventricular cardiomyocytes causes an acute and transient increase in Ca2+ spark rate
,” Circ. Res.
104
, 787
–795
(2009
).154.
Z.-Y.
Yu
et al., “Piezo1 is the cardiac mechanosensor that initiates the cardiomyocyte hypertrophic response to pressure overload in adult mice
,” Nat. Cardiovasc. Res.
1
, 577
–591
(2022
).155.
S.
Cho
et al., “Mechanosensing by the lamina protects against nuclear rupture, DNA damage, and cell-cycle arrest
,” Dev. Cell.
49
, 920
–935
(2019
).156.
G.
West
et al., “Deleterious assembly of the lamin A/C mutant p.S143P causes ER stress in familial dilated cardiomyopathy
,” J. Cell Sci.
129
, 2732
–2743
(2016
).157.
Y.
Zhao
et al., “Unusual localization and translocation of TRPV4 protein in cultured ventricular myocytes of the neonatal rat
,” Eur. J. Histochem.
56
, e32
(2012
).158.
M.
Song
, Y.
Jang
, S.-J.
Kim
, and Y.
Park
, “Cyclic stretching induces maturation of human-induced pluripotent stem cell-derived cardiomyocytes through nuclear-mechanotransduction
,” Tissue Eng. Regener. Med.
19
, 781
–792
(2022
).159.
M. H.
Mokalled
et al., “Myocardin-related transcription factors are required for cardiac development and function
,” Dev. Biol.
406
, 109
–116
(2015
).160.
Y.
Guo
et al., “Sarcomeres regulate murine cardiomyocyte maturation through MRTF-SRF signaling
,” Proc. Natl. Acad. Sci. U. S. A.
118
, e2008861118
(2021
).161.
T.
Dorn
et al., “Interplay of cell-cell contacts and RhoA/MRTF-A signaling regulates cardiomyocyte identity
,” EMBO J.
37
, e98133
(2018
).162.
W. J.
Nelson
and R.
Nusse
, “Convergence of Wnt, β-catenin, and cadherin pathways
,” Science
303
, 1483
–1487
(2004
).163.
J. S.
Heo
and J.-C.
Lee
, “β-catenin mediates cyclic strain-stimulated cardiomyogenesis in mouse embryonic stem cells through ROS-dependent and integrin-mediated PI3K/Akt pathways
,” J. Cell. Biochem.
112
, 1880
–1889
(2011
).164.
J. L.
Young
, K.
Kretchmer
, M. G.
Ondeck
, A. C.
Zambon
, and A. J.
Engler
, “Mechanosensitive kinases regulate stiffness-induced cardiomyocyte maturation
,” Sci. Rep.
4
, 6425
(2014
).165.
W.
Cai
et al., “A nodal-to-TGFβ cascade exerts biphasic control over cardiopoiesis
,” Circ. Res.
111
, 876
–881
(2012
).166.
I.
Banerjee
et al., “Cyclic stretch of embryonic cardiomyocytes increases proliferation, growth, and expression while repressing Tgf-β signaling
,” J. Mol. Cell. Cardiol.
79
, 133
–144
(2015
).167.
V.
Divakaran
et al., “Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading
,” Circ. Heart Failure
2
, 633
–642
(2009
).168.
H.
Tokola
et al., “Bone morphogenetic protein-2: A potential autocrine/paracrine factor in mediating the stretch activated B-type and atrial natriuretic peptide expression in cardiac myocytes
,” Mol. Cell. Endocrinol.
399
, 9
–21
(2015
).169.
J.
Wang
, S.
Liu
, T.
Heallen
, and J. F.
Martin
, “The Hippo pathway in the heart: Pivotal roles in development, disease, and regeneration
,” Nat. Rev. Cardiol.
15
, 672
–684
(2018
).170.
E.
Bassat
et al., “The extracellular matrix protein agrin promotes heart regeneration in mice
,” Nature
547
, 179
–184
(2017
).171.
K.-I.
Wada
, K.
Itoga
, T.
Okano
, S.
Yonemura
, and H.
Sasaki
, “Hippo pathway regulation by cell morphology and stress fibers
,” Development
138
, 3907
–3914
(2011
).172.
D.
Mosqueira
et al., “Hippo pathway effectors control cardiac progenitor cell fate by acting as dynamic sensors of substrate mechanics and nanostructure
,” ACS Nano
8
, 2033
–2047
(2014
).173.
L.
LeBlanc
, N.
Ramirez
, and J.
Kim
, “Context-dependent roles of YAP/TAZ in stem cell fates and cancer
,” Cell. Mol. Life Sci.
78
, 4201
–4219
(2021
).174.
I. K.
Adiga
and R. N.
Renuka
, “Multiple signaling pathways coordinately mediate reactive oxygen species dependent cardiomyocyte hypertrophy
,” Cell Biochem. Funct.
26
, 346
–351
(2008
).175.
C.
Murdoch
, M.
Zhang
, A.
Cave
, and A.
Shah
, “NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure
,” Cardiovasc. Res.
71
, 208
–215
(2006
).176.
K.
Yoshioka
et al., “Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats
,” Am. J. Physiol.-Heart Circ. Physiol.
309
, H1782
–H1791
(2015
).177.
J.
Pan
et al., “PKC mediates cyclic stretch-induced cardiac hypertrophy through Rho family GTPases and mitogen-activated protein kinases in cardiomyocytes
,” J. Cell. Physiol.
202
, 536
–553
(2004
).178.
T. Y.
Wong
, “Mechanical stretching simulates cardiac physiology and pathology through mechanosensor Piezo1
,” FASEB J.
33
, 785
(2019
).179.
E.
Mirdamadi
, J. W.
Tashman
, D. J.
Shiwarski
, R. N.
Palchesko
, and A. W.
Feinberg
, “FRESH 3D bioprinting a full-size model of the human heart
,” ACS Biomater. Sci. Eng.
6
, 6453
–6459
(2020
).180.
C. S.
Ong
et al., “Biomaterial-free three-dimensional bioprinting of cardiac tissue using human induced pluripotent stem cell derived cardiomyocytes
,” Sci. Rep.
7
, 4566
(2017
).181.
N.
Noor
et al., “3D printing of personalized thick and perfusable cardiac patches and hearts
,” Adv. Sci.
6
, 1900344
(2019
).182.
A.
Lee
et al., “3D bioprinting of collagen to rebuild components of the human heart
,” Science
365
, 482
(2019
).183.
V.
Swaminathan
and M.
Gloerich
, “Decoding mechanical cues by molecular mechanotransduction
,” Curr. Opin. Cell Biol.
72
, 72
–80
(2021
).184.
A. H.
Lewis
, A. F.
Cui
, M. F.
McDonald
, and J.
Grandl
, “Transduction of repetitive mechanical stimuli by Piezo1 and Piezo2 ion channels
,” Cell Rep.
19
, 2572
–2585
(2017
).185.
M. H.
Jo
, W. T.
Cottle
, and T.
Ha
, “Real-time measurement of molecular tension during cell adhesion and migration using multiplexed differential analysis of tension gauge tethers
,” ACS Biomater. Sci. Eng.
5
, 3856
–3863
(2018
).186.
Y.
Qin
et al., “A stretchable scaffold with electrochemical sensing for 3D culture, mechanical loading, and real-time monitoring of cells
,” Adv. Sci.
8
, e2003738
(2021
).187.
H.
Liu
, J. F.
Usprech
, P. K.
Parameshwar
, Y.
Sun
, and C. A.
Simmons
, “Combinatorial screen of dynamic mechanical stimuli for predictive control of MSC mechano-responsiveness
,” Sci Adv
7
(19
), eabe7204
(2021
).188.
Y.
Rudy
and J. R.
Silva
, “Computational biology in the study of cardiac ion channels and cell electrophysiology
,” Q. Rev. Biophys.
39
, 57
–116
(2006
).189.
F.
Liu
et al., “A new model of myofibroblast-cardiomyocyte interactions and their differences across species
,” Biophys. J.
120
, 3764
–3775
(2021
).190.
B.
Sari
et al., “Omics technologies for high-throughput-screening of cell-biomaterial interactions
,” Mol. Omics
18
, 591
–615
(2022
).191.
M.
Darnell
and D. J.
Mooney
, “Leveraging advances in biology to design biomaterials
,” Nat. Mater.
16
, 1178
–1185
(2017
).192.
M. N.
Hirt
et al., “Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology
,” J. Mol. Cell. Cardiol.
81
, 1
–9
(2015
).193.
A. E.
Saliba
, A. J.
Westermann
, S. A.
Gorski
, and J.
Vogel
, “Single-cell RNA-seq: Advances and future challenges
,” Nucl. Acids Res.
42
, 8845
–8860
(2014
).194.
A. L.
Koenig
et al., “Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure
,” Nat. Cardiovasc. Res.
1
, 263
–280
(2022
).195.
C.
Giesen
et al., “Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
,” Nat. Methods
11
, 417
–422
(2014
).196.
J.-R.
Lin
, M.
Fallahi-Sichani
, and P. K.
Sorger
, “Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method
,” Nat. Commun.
6
, 8390
(2015
).197.
S. C.
Bendall
et al., “Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum
,” Science
332
, 687
–696
(2011
).198.
P.
Hoang
et al., “Engineering spatial-organized cardiac organoids for developmental toxicity testing
,” Stem Cell Rep.
16
, 1228
–1244
(2021
).199.
A. C.
Daly
, M. D.
Davidson
, and J. A.
Burdick
, “3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels
,” Nat. Commun.
12
, 753
(2021
).200.
M. A.
Skylar-Scott
et al., “Orthogonally induced differentiation of stem cells for the programmatic patterning of vascularized organoids and bioprinted tissues
,” Nat. Biomed. Eng.
6
, 449
–462
(2022
).© 2023 Author(s). Published under an exclusive license by AIP Publishing.
2023
Author(s)
You do not currently have access to this content.
